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Gray/white matter contrast (GWC) decreases with aging and has been found to
be a useful MRI biomarker in Alzheimer’s disease (AD), but its utility in Parkinson’s
disease (PD) patients has not been investigated. The aims of the study were to test
whether GWC is sensitive to aging changes in PD patients, if PD patients differ from
healthy controls (HCs) in GWC, and whether the use of GWC data would improve the
sensitivity of cortical thickness analyses to differentiate PD patients from controls. Using
T1-weighted structural images, we obtained individual cortical thickness and GWC
values from a sample of 90 PD patients and 27 controls. Images were processed with
the automated FreeSurfer stream. GWC was computed by dividing the white matter
(WM) by the gray matter (GM) values and projecting the ratios onto a common surface.
The sample characteristics were: 52 patients and 14 controls were males; mean age of
64.4 ± 10.6 years in PD and 64.7 ± 8.6 years in controls; 8.0 ± 5.6 years of disease
evolution; 15.6 ± 9.8 UPDRS; and a range of 1.5–3 in Hoehn and Yahr (H&Y) stage.
In both PD and controls we observed significant correlations between GWC and age
involving almost the entire cortex. When applying a stringent cluster-forming threshold
of p < 0.0001, the correlation between GWC and age also involved the entire cortex in
the PD group; in the control group, the correlation was found in the parahippocampal
gyrus and widespread frontal and parietal areas. The GWC of PD patients did not differ
from controls’, whereas cortical thickness analyses showed thinning in temporal and
parietal cortices in the PD group. Cortical thinning remained unchanged after adjusting
for GWC. GWC is a very sensitive measure for detecting aging effects, but did not
provide additional information over other parameters of atrophy in PD.
Keywords: Parkinson’s disease, gray/white matter contrast, cortical thickness, aging, magnetic resonance
imaging
INTRODUCTION
Gray/white matter contrast (GWC) extracted from T1-weighted MRI images is a measure of
blurring between the boundaries of these brain compartments. Even though the neurobiological
bases of this measure are not well understood, several studies suggested that the GWC could be
an indicator of local variations in tissue integrity andmyelin degradation (Koenig, 1991), increasing
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water content in the white matter (WM; Bansal et al., 2013), or
iron deposition (Ogg and Steen, 1998). GWC changes have been
associated with aging (Davatzikos and Resnick, 2002), showing
a pattern of contrast decay mainly in frontal (Westlye et al.,
2009) and temporo-parietal regions; results have been similar
or even statistically stronger than those obtained using cortical
thickness measures (Salat et al., 2009; Westlye et al., 2009). The
interpretation of age-related GWC reductions is still a matter
of discussion. An early study that measured T1 and T2 signal
intensities in gray matter (GM) and white matter (WM) of
elderly subjects suggested that these measures could be reflecting
an increase in water content in the WM and neuronal loss in
GM (Magnaldi et al., 1993). An alternative interpretation is that
GWC reflects changes in myelination degree. In a recent elegant
study with a large sample of normal subjects, using cortical
reconstruction methods to obtain GWC that greatly improve
the delineation of the GM/WM boundary (Dale et al., 1999),
Vidal-Piñeiro et al. (2016) observed that GWC seems especially
related to age-related myelin variations underlying the GM/WM
boundary of lightly myelinated areas. The authors proposed that
GWC might be a useful technique to track myelin breakdown in
critical brain areas in clinical populations.
Consequently, GWC could be an indirect marker of
changes in histological properties of the brain that might
have a significant impact on neurodegenerative processes. In
Alzheimer’s disease (AD) patients, cortical thickness analyses
after adjusting for GWC have shown regionally enlarged and
strengthened results in inferior and superior parietal gyri;
precuneus; and medial and lateral frontal as well as temporal
regions. It has been suggested that this procedure probably
corrects for the overestimation of thickness in subjects with
regionally reduced tissue contrast (Westlye et al., 2009). GWC
has also been proven useful to detect patients with mild
cognitive impairment who will later convert to dementia after
adjusting this measure for cortical thickness, hippocampal
volume, APOE4 status and scanner type (Jefferson et al., 2015).
In Parkinson’s disease (PD), magnetic resonance imaging
(MRI) has revealed cortical atrophy mainly through voxel-
based morphometry and cortical thickness measures (Hall et al.,
2016; Agosta et al., 2017) and WM changes using diffusion
tensor imaging (Hall et al., 2016). However, to the best of our
knowledge, there are no previous studies on GWC. Therefore,
the aims of our study were to test: (1) whether GWC is sensitive
to aging changes in PD patients; (2) whether PD patients differ
from healthy controls (HCs) in GWC; and (3) whether GWC
data would improve the sensitivity of cortical thickness analyses
to differentiate between PD patients and controls.
MATERIALS AND METHODS
Participants
The study included 121 consecutive PD patients recruited from
an outpatient movement disorders clinic (PD and Movement
Disorders Unit, Department of Neurology, Hospital Clinic,
Barcelona, Catalonia, Spain) and 49 HC who volunteered to
take part in studies addressing age-related processes at the
Institut de l’Envelliment (Aging Institute). The inclusion criteria
considered by the neurologists involved (MJM, FV and YC) were:
(1) fulfilling the UK PD Society Brain Bank diagnostic criteria
for PD (Hughes et al., 1992) and (2) no surgical treatment with
deep brain stimulation. The exclusion criteria were: (1) presence
of dementia according to the Movement Disorders Society
criteria for PD (Emre et al., 2007); (2) Hoehn and Yahr
(H&Y) scale (Hoehn and Yahr, 1967) score greater than 3;
(3) juvenile-onset PD; (4) presence of psychiatric or neurological
comorbidity; (5) low global intelligence quotient estimated by
the Vocabulary subtest of the Wechsler Adult Intelligence
Scale, 3rd edition (scaled score 7 points); (6) Mini-Mental state
examination (Folstein et al., 1975) score below 25; (7) presence
of claustrophobia; (8) pathological MRI findings other than
mild WM hyperintensities in long-TR sequences; and (9) MRI
artifacts. Ninety PD patients and 27 healthy volunteers were
finally selected. Twelve patients and eight controls were excluded
because they fulfilled criteria for dementia or other neurological
disease, six PD patients for psychiatric comorbidity, one PD
patient who scored higher than 3 on the H&Y scale, one
PD patient with young-onset PD, three PD patients and one
control who had low global intelligence quotient scores, two PD
patients for claustrophobia, three healthy subjects who did not
complete the protocol, and two controls and two PD patients
because of MRI artifacts. Five controls were excluded because of
preprocessing errors detected by FreeSurfer. We also excluded
four patients and three controls aged younger than 50 years.
This study received approval by the ethics committee of
the University of Barcelona (IRB00003099). Written informed
consent was obtained from all study subjects after full
explanation of the procedures involved.
Clinical and Neuropsychological
Assessment
Motor symptoms were assessed by means of the UPDRS-III
motor section (Elton, 1987). H&Y staging and disease duration
was also recorded. All PD patients were taking antiparkinsonian
drugs, consisting of different combinations of L-DOPA,
catechol-O-methyltransferase (COMT) inhibitors, monoamine
oxidase inhibitors, dopamine agonists, and amantadine. In order
to standardize doses, the L-DOPA equivalent daily dose (LEDD;
Tomlinson et al., 2010) was calculated.
We used a neuropsychological battery following the
Movement Disorders Society task force recommendations
(Litvan et al., 2012), bar language, for which a single measure
was used, and executive functions, for which phonemic and
semantic verbal fluency were used as two distinct proxies.
Detailed information can be found in a previous study by our
group (Uribe et al., 2016).
Image Acquisition and Preprocess
Magnetic resonance images were acquired with a 3T scanner
(MAGNETOMTrio, Siemens, Germany). The scanning protocol
included high-resolution three-dimensional T1-weighted
images acquired in the sagittal plane (TR = 2300 ms,
TE = 2.98 ms, TI = 900 ms, 240 slices, FOV = 256 mm;
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matrix size = 256 × 256; 1 mm isotropic voxel) and an axial
FLAIR sequence (TR = 9000 ms, TE = 96 ms).
Cortical thickness was estimated using the automated
FreeSurfer stream (version 5.1; available at: https://surfer.nmr.
mgh.harvard.edu/). The procedures carried out by FreeSurfer
include removal of nonbrain data, intensity normalization (Fischl
et al., 2001), tessellation of the GM/WM boundary, automated
topology correction (Dale et al., 1999; Ségonne et al., 2007) and
accurate surface deformation to identify tissue borders (Dale
and Sereno, 1993; Fischl and Dale, 2000; Fischl et al., 2002).
Cortical thickness is then calculated as the distance between
the WM and GM surfaces at each vertex of the reconstructed
cortical mantle (Fischl et al., 2002). In our study, results for each
subject were visually inspected to ensure accuracy of registration,
skull stripping, segmentation and cortical surface reconstruction.
Maps were smoothed using a circularly symmetric Gaussian
kernel across the surface with a full width at half maximum
(FWHM) of 30 mm.
Intensity maps forWM and GMwere created using the values
of the T1-weighted signal of the WM at 1 mm below the white
surface, and the values of the GM were taken at half of the
thickness of the cortex. Finally, WM/GM intensity contrast maps
were calculated using the percentage contrast between WM and
GM intensities. Before performing group statistical analyses, the
resulting WM, GM andWM/GM contrast maps were mapped to
a common surface and smoothed with a 30 mm Gaussian kernel
of FWHM1.
Statistical Analyses
Demographic, neuropsychological, and clinical statistical
analyses were conducted using IBM SPSS Statistics 24.0 (IBM
Corp., Armonk, New York, NY, USA). Student’s t- or Mann-
Whitney’s U tests were used for testing group differences in
demographic and clinical variables.
Multiple regression analyses were performed to test the
relationship between GWC and age, years of disease evolution,
1https://surfer.nmr.mgh.harvard.edu/fswiki/pctsurfcon
age of disease onset, UPDRS-III and LEDD. Intergroup cortical
thickness and GWC comparisons were performed using a vertex-
by-vertex general linear model with FreeSurfer. The model
included cortical thickness or GWC as a dependent factor and
group as an independent factor. A second model included
cortical thickness as the dependent factor andGWC as a nuisance
covariate. All results were corrected for multiple comparisons
using precached cluster-wise Monte Carlo simulation with
10,000 iterations. Reported cortical regions reached a two-tailed
corrected significance level of p< 0.05. Different cluster-forming
thresholds were applied at p< 0.05, p< 0.01 and p< 0.0001 with
the aim to identify specific regional correlations between age and
GWC.
RESULTS
Table 1 shows the sociodemographic and clinical data of
the groups and the corresponding group comparison. There
were no significant differences between groups in age, sex, or
education. PD patients scored significantly lower than HC in
MMSE. Forty-four percent of the patients had mild cognitive
impairment, being the attention and working memory the most
frequently impaired domains (59%), followed by the memory
domain (40%). Executive functions were impaired in 33% of the
patients, visuospatial functions in 30%, and the language domain
in 8% of the PD sample.
Regression analyses between GWC maps and age showed
significant correlations involving almost the entire brain in both
HC and PD groups when applying cluster forming thresholds
at p < 0.05 and p < 0.01. At the p < 0.0001 threshold for the
HC group, the significant correlation cluster involved bilateral
parahippocampal, left lateral temporal, and widespread bilateral
frontal and parietal regions, whereas in the PD group the
correlation also involved the entire cortex (Figures 1, 2 and
Table 2). There were no significant correlations between GWC
and any clinical disease-related variables.
TABLE 1 | Demographic and clinical data.
PD (n = 90) HC (n = 27) Stats (p value)
Sex, male/female 52/38 14/13 0.297 (0.586)a
Age, years, mean ± SD 64.4 ± 10.6 64.9 ± 8.4 0.236 (0.814)b
Education, years, median ± IQ range 10.0 ± 8.0 9.0 ± 9.0 1098.0 (0.447)c
MMSE, median ± IQ range 29.0 ± 1.0 30.0 ± 1.0 841.5 (0.009)c
Disease duration, years, median ± IQ range 6.0 ± 9.0 NA NA
Age of onset, years, mean ± SD 56.3 ± 11.6 NA NA
UPDRS part III, median ± IQ range 13.0 ± 13.0 NA NA
Hoehn and Yahr stage, n 1/1.5/2/2.5/3 22/5/44/9/10 NA NA
LEDD, mg, median ± IQ range 700.0 ± 833.0 NA NA
Mild cognitive impairment, n (%) 40 (44.4) NA NA
Visuospatial functions, n (%) 27 (30.0) NA NA
Executive functions, n (%) 30 (33.3) NA NA
Memory, n (%) 36 (40.0) NA NA
Attention and working memory, n (%) 53 (58.9) NA NA
Language, n (%) 7 (7.8) NA NA
Abbreviations: HC, healthy controls; IQ range, interquartile range; LEDD, L-DOPA equivalent daily dose; MMSE, Mini-Mental State Examination; NA, not applicable;
PD, Parkinson’s disease; UPDRS part III, Unified Parkinson’s Disease Rating Scale motor section. aPearson’s chi-squared test was used. bStudent’s t-test was used.
cMann-Whitney U test was used.
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FIGURE 1 | Gray/white matter contrast (GWC) correlations with age in the patients group. Color maps indicate negative correlation between age and GWC. Three
levels of cluster-forming thresholds are shown. All results were corrected by Monte Carlo simulation at a cluster-wise p < 0.05.
FIGURE 2 | GWC correlations with age in the controls group. Color maps indicate negative correlation between age and GWC. Three levels of cluster-forming
thresholds are shown. All results were corrected by Monte Carlo simulation at a cluster-wise p < 0.05.
GWC comparison between groups did not show significant
results after Monte Carlo simulation at cluster-wise probability
significance level set at any p-value threshold. Cortical thickness
comparison between groups at the p < 0.05 threshold
showed significant cortical thinning in PD patients, mainly
in medial parieto-temporal regions including bilateral
fusiform and parahippocampal gyri, cuneus, isthmus
cingulate, and precuneus. Differences in dorsal cortices
involved bilateral lateral occipital, as well as inferior and
superior parietal cortices (Figure 3A and Table 3). At the
p < 0.01 threshold, previous differences observed in right
medial anterior temporal regions, left precuneus, and right
lateral occipital were not statistically significant (Figure 3B,
Table 3). Similar results were obtained after controlling this
analysis for GWC (Figures 3C,D). There were no significant
differences between groups at the p < 0.0001 cluster-
forming threshold, except for a small cluster of thinning
in the right lingual gyrus when using GWC as a regressor
(Table 3).
DISCUSSION
Tissue-contrast intensity showed sensitivity to aging effects.
However, this measure: (1) did not differ between PD patients
and the age-matched control group; (2) did not correlate with
any clinical disease-related variable; and (3) the between-group
differences in cortical thickness remained similar after correction
for GWC.
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TABLE 2 | Gray/white matter contrast information from the correlations with age in PD patients and HCs.
Cortical area Cluster size (mm2) Stats P-value MNI coordinates (x y z)1
PD patients—age correlation p < 0.05
Left precentral 75,459.3 −16.434 0.0002 −51 −3 7
Right postcentral 74,772.5 −17.129 0.0002 47 −11 18
PD patients—age correlation p < 0.01
Left precentral 74,640.3 −16.434 0.0002 −51 −3 7
Right postcentral 73,577.6 −17.129 0.0002 47 −11 18
PD patients—age correlation p < 0.0001
Left precentral 72,108.4 −16.434 0.0002 −51 −3 7
Right postcentral 70,658.4 −17.129 0.0002 47 −11 18
Healthy controls—age correlation p < 0.05
Left precentral 75,239.6 −8.133 0.0002 −43 1 13
Right isthmus cingulate 75,795.5 −7.687 0.0002 4 −48 25
Healthy controls—age correlation p < 0.01
Left precentral 73,192.4 −8.133 0.0002 −43 1 13
Right isthmus cingulate 72,242.8 −7.687 0.0002 4 −48 25
Healthy controls—age correlation p < 0.0001
Left precentral 54,752.8 −8.133 0.0002 −43 1 13
Right isthmus cingulate 36,528.7 −7.687 0.0002 4 −48 25
Right parahippocampal 869.0 −6.865 0.0004 20 −37 −12
1MNI305 space. Abbreviations: PD, Parkinson’s disease; MNI, Montreal Neurological Institute. Results were obtained using Monte Carlo simulation with 10,000 iterations
applied to gray/white matter contrast maps to provide cluster-wise correction for multiple comparisons (1.3, 2.0 and 4.0). Significant clusters are reported at p < 0.05.
In agreement with previous studies, we found that GWC is a
very sensitive measure for the effects of aging on the brain. We
showed significant correlations between GWC and age involving
almost the entire cortex in both HC and PD groups. Decrease
in GWC contrast related to normal aging was reported in a
large sample of subjects by Salat et al. (2009). These authors
also found that aging altered a large portion of the cortical
mantle. Similar results were obtained in the work by Westlye
et al. (2009) in a sample of 1189 normal subjects. However,
these studies reported regional patterns of atrophy suggesting an
increased susceptibility of frontal regions. The differences with
our data could be explained by the sample characteristics; in these
two previous studies, the samples included young middle-age
and older adults, while all subjects in our sample were older.
Frontal involvement is likely to be seen in early stages of aging.
The age-related WM/GM intensity contrast decrease has been
associated with the decline of WM intensity on T1-weighted
images (Salat et al., 2009). A recent longitudinal study also
supports this hypothesis and emphasizes the vulnerability of
certain areas based on the degree of myelination (Vidal-Piñeiro
et al., 2016). Assuming the hypothesis that GWC loss is
due to demyelination, it might be concluded that PD is a
degenerative illness without demyelination effects different from
those associated with aging per se.
In neurodegenerative diseases such as AD, GWC decay has
been found to be larger than in HC. Individuals with AD
exhibited reduced GM to WM tissue contrast in several regions
throughout the cortical mantle, with particularly strong effects
in temporal and limbic areas (Salat et al., 2011). GWC in these
areas correlated with hippocampal volumes in AD, whereas in
controls the hippocampal volume was associated with GWC
globally across the cortical mantle (Salat et al., 2011). Moreover,
it has been reported that GWC is able to detect cerebral changes
in periods of time as short as 2 years. Compared to HC, AD
patients showed regional differences in themedial temporal lobes
(Grydeland et al., 2013). The lack of sensitivity in PD compared
with AD could be explained by the differential neuropathological
basis underlying both degenerative processes. Our sample is
composed of non-demented subjects; we therefore cannot rule
out that GWC might be sensitive in patients with PD-related
dementia. Even more interestingly, GWC might be able to
distinguish demented PD patients who have comorbid AD type
pathology as has been described using β-amyloid PET (Akhtar
et al., 2016). In this line, Salat et al. (2011) reported that GWC
changes are regionally selective to areas known to show AD
pathology. GWC assessment might be insensitive to the cortical
changes due to α-synuclein pathology. Another reason for the
lack of sensitivity of GWC to brain atrophy in PD would be
the variability of cortical thinning in PD. Other studies using
cortical thickness to compare medicated PD patients and healthy
subjects reported similar regions of cortical thinning than those
found in the present study (Pereira et al., 2012; Garcia-Diaz et al.,
2014; Segura et al., 2014; Mak et al., 2015). Posterior cortical
atrophy has also been reported in de novo PD patients (Pereira
et al., 2014; Uribe et al., 2018). However, in a previous study
with a great part of the current sample addressed to identify
patterns of cortical thinning in PD, we found that there is a
subgroup of patients without manifest cortical atrophy (Uribe
et al., 2016).
Moreover, previous studies showed that the inclusion of
GWC as a covariate in cortical thickness analyses increased
both age and diagnostic sensitivity in several regions (Westlye
et al., 2009). Recently, using Alzheimer Disease Neuroimaging
Initiative (ADNI) data, it has been reported that GWC did not
differentiate normal subjects from MCI or AD subjects (Bauer
et al., 2014). The authors only found that, after adjusting for
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FIGURE 3 | Vertex-wise comparison of cortical thickness differences with and without GWC as regressor. Color maps indicate cortical thinning significant differences
between Parkinson’s disease (PD) patients and controls at cluster-forming thresholds of (A) p < 0.05 and (B) p < 0.01. Color maps indicate cortical thinning
significant differences between groups with GWC as nuisance factor at (C) p < 0.05 and (D) p < 0.01. All results were corrected by Monte Carlo simulation at
cluster-wise p < 0.05.
GWC, effect sizes for the differences in cortical thickness between
groups were increased.
Our results evidenced cortical thinning in PD patients
in comparison with HC, mainly in temporo-parietal regions.
However, we did not find significant differences in GWC, or any
increased sensitivity of cortical thickness results after correction
for this MRI parameter. This suggests that cortical thickness and
GWC are independent measures, since differences in cortical
thickness in PD vs. controls did not change after controlling for
this measure. Salat et al. (2009) found that the effect of GWC
changes is greater than those of morphometric changes such as
cortical thinning, but also pointed out that both measures were
statistically independent.
Previous studies seem to demonstrate that changes in GWC
are mainly due to WM degeneration in lightly myelinated
regions with age-related vulnerability. In PD, despite previous
descriptions of WM abnormalities seen through DTI parameters
(Hall et al., 2016; Agosta et al., 2017), changes may not be
sufficient to be detected by GWC analyses when compared with
healthy aging subjects. It is important to remark that the current
study is cross-sectional, and it is possible that the GWC would
be sensitive to degeneration over time in PD, similarly to the
findings reported in AD by Grydeland et al. (2013), and also by
Vidal-Piñeiro et al. (2016) in a study of normal aging that showed
that longitudinal GWC changes can be detected in a healthy
population over a relatively short period of time.
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TABLE 3 | Cortical thickness information from the analysis between HCs and PD patients.
Cortical area Cluster size (mm2) Stats P-value MNI coordinates (x y z)1
PD patients < healthy controls at p < 0.05
Left superior parietal 20,272.3 3.826 0.0002 −24 −82 23
Right lingual 25,478.3 4.274 0.0002 10 −59 −0
PD patients < healthy controls at p < 0.01
Left superior parietal 11,282.9 3.826 0.0002 −24 −82 23
Right lingual 4059.7 4.274 0.0002 10 −59 −0
Right superior parietal 9925.9 4.256 0.0002 27 −59 47
PD patients < healthy controls with GWC as per-vertex regressor at p < 0.05
Left superior parietal 20,330.9 3.719 0.0002 −22 −84 21
Right lingual 22,992.3 4.531 0.0002 11 −57 −0
PD patients < healthy controls with GWC as per-vertex regressor at p < 0.01
Left superior parietal 8371.8 3.719 0.0002 −22 −84 21
Left supramarginal 1794.7 3.213 0.0272 −50 −52 39
Right lingual 3349.2 4.531 0.0004 11 −57 −0
Right superior parietal 101,165 4.067 0.0002 27 −60 47
PD patients < healthy controls with GWC as per-vertex regressor at p < 0.0001
Right lingual 208.3 4.531 0.0286 11 −57 −0
1MNI305 space. Abbreviations: GWC, gray to white matter contrast; PD, Parkinson’s disease; MNI, Montreal Neurological Institute. Results were obtained using Monte
Carlo simulation with 10.000 iterations applied to cortical thickness maps to provide cluster-wise correction for multiple comparisons (1.3, 2.0 and 4.0). Significant clusters
were reported at p < 0.05.
One strength of the present study was the utilization of
different stringent cluster-forming thresholds in an attempt
to identify specific regions across the cortical mantle that
most strongly correlated with age. In contrast to initial studies
that used T1, spin density, and T2 values of white and GM
(Magnaldi et al., 1993) or segmentation algorithms (Davatzikos
and Resnick, 2002) to estimate GWC, we used a cortical
reconstruction approach improving the delineation of the
GM/WM boundary (Dale et al., 1999). On the other hand, the
lack of differences between PD patients and controls in the GWC
could be due to the small sample size of controls. However,
similarly to other studies using cortical thickness measures with
unbalanced samples, we found significant differences between
patients and controls using such measure (Lyoo et al., 2010;
Pagonabarraga et al., 2013; Segura et al., 2014; Uribe et al.,
2016).
In conclusion, GWC is a very sensitive measure for detecting
aging effects, but may not be helpful in differentiating atrophy
patterns between PD patients and controls.
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